Authors: Tamminga, WJ Wemer, J Oosterhuis, B Wieling, J Touw, DJ de Zeeuw, RA de Leij, LFMH Jonkman, JHG

Citation: Wj. Tamminga et al., Mephenytoin as a probe for CYP2C19 phenotyping: effect of sample storage, intra-individual reproducibility and occurrence of adverse events, BR J CL PH, 51(5), 2001, pp. 471-474

Authors: Wieling, J Tamminga, WJ Sakiman, EP Oosterhuis, B Wemer, J Jonkman, JHG

Citation: J. Wieling et al., Evaluation of analytical and clinical performance of a dual-probe phenotyping method for CYP2D6 polymorphism and CYP3A4 activity screening, THER DRUG M, 22(4), 2000, pp. 486-496

Authors: Hempenius, J Steenvoorden, RJJM Lagerwerf, FM Wieling, J Jonkman, JHG

Citation: J. Hempenius et al., 'High throughput' solid-phase extraction technology and turbo ionspray LC-MS-MS applied to the determination of haloperidol in human plasma, J PHARM B, 20(6), 1999, pp. 889-898

Authors: Tamminga, WJ Wemer, J Oosterhuis, B Wieling, J Wilffert, B de Leij, LFMH de Zeeuw, RA Jonkman, JHG

Citation: Wj. Tamminga et al., CYP2D6 and CYP2C19 activity in a large population of Dutch healthy volunteers: indications for oral contraceptive-related gender differences, EUR J CL PH, 55(3), 1999, pp. 177-184